- Hepatitis C virus (HCV) infects the liver, causing inflammation. If left untreated, it also results in a gradual loss of healthy tissue and its replacement with ...
- Historically, treatment for chronic hepatitis C virus (HCV) infection consisted of weekly injections of interferon accompanied by daily oral doses of the ...
- Doctors in Barcelona recently reported an unexpected increase in liver cancer recurrence in people who had been or who are being treated for chronic hepatitis C ...
- Doctors in Vienna, Austria, recently reported a group of cases of liver cancer in 19 participants whose hepatitis C virus (HCV) was treated with direct acting ...
- Spurred by reports from other cities, doctors in Bologna, Italy, have reviewed their database to assess possible risk factors for liver cancer development and ...
- As mentioned earlier in this issue of TreatmentUpdate, reports from Barcelona and Vienna have emerged suggesting that exposure to direct acting antivirals ...
- In TreatmentUpdate 215 we published a short guide about some classes of treatment for hepatitis C virus (HCV). Before reading the rest of the reports in this ...
- The hepatitis C virus (HCV) protein NS5A plays an important role in the creation of new copies of HCV. As a result, pharmaceutical companies have developed (and ...
- In a study sponsored by Gilead Sciences called Astral-5, researchers in the United States tested the fixed-dose combination of sofosbuvir + velpatasvir (sold as ...
- Anal cancer typically develops over a period of years, beginning with a precancerous condition called anal dysplasia.